Guidance to Transfer ‘Bench-Ready’ Medical Technology into Usual Clinical Practice: Case Study – Sensors and Spectrometer Used in EPR Oximetry

Abstract

This paper considers the critical role that academics can have in the development of clinical innovations and especially how their impact can be optimized. The focus should be on establishing the safety and efficacy of new approaches while also incorporating human factors and human use considerations into the inventions. It is very advantageous to work in concert with the end-users (operators and clinicians) to help ensure that the innovation will be useful and feasible to be incorporated into actual clinical practice as intended. This strategy enables developments to tackle real clinical needs by providing novel strategies to improve patient care while using solutions that fit into clinical practice and that are welcomed by patients and clinical staff. These principles are illustrated by a case study of the development of clinical in vivo EPR oximetry.

The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia

“…EPR oxygen imaging also demonstrated its predictive value for tumor control according to tumor oxygenation level and radiation dose (Elas et al, 2008;Elas et al, 2013;Epel et al, 2019). So far, a limited number of studies have been applied in humans to measure by EPR the oxygen level in superficial tumors (Swartz et al, 2014;Swartz et al, 2016;Flood et al, 2018;Jeong et al, 2019;Flood et al, 2020;Schaner et al, 2021).…”

The Pig as a Translational Animal Model for Biobehavioral and Neurotrauma Research

“…Another important aspect of biomedical engineering is the development of new equipment and testing the diagnostic and prognostic potential of new methods and therapies. The pig is instrumental in this regard, as its large body size allows the use of equipment and modalities with results that can be immediately applicable to humans [ 11 ].…”